Overview

A Study of JNJ-64281802 for the Prevention of Dengue Infection

Status:
Not yet recruiting
Trial end date:
2025-05-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the prophylactic effect of JNJ-64281802 with respect to the prevention of laboratory-confirmed dengue virus (DENV) infection up to last day of dosing among participants who have no evidence of current DENV infection at baseline.
Phase:
Phase 2
Details
Lead Sponsor:
Janssen Research & Development, LLC